Baozun Releases 2025 Chairman Letter
SHANGHAI, April 23, 2026 /PRNewswire/ -- Dear Shareholders: First of all, this is a letter I write to you by myself, and it's a pure human writing without any involvement of AI (though yes I use AI everyday for a lot of things). As a company, we are...
Philip Yeo's EDIS Expresses Support for Mencast's Growth Strategy; Becomes Top 20 Shareholder
SINGAPORE, April 17, 2026 /PRNewswire/ -- Economic Development Innovations Singapore ("EDIS") today announced its support for Mencast Holdings Ltd. (5NF.SI) ("Mencast"), reaffirming its confidence in the company's long-term strategy and growth...
Lanvin Group Advances Strategic Transformation and Portfolio Optimization Amid Challenging Luxury Market
Preliminary FY2025 revenue of €240.5 million, down 17.6% year-over-year, reflecting industry headwinds and the Group's proactive transformation and restructuring initiatives. Figures exclude Caruso following its strategic carve-out announced on...
Robo.ai Inc. Submits Application to Participate in the Pre-Restructuring Strategic Investor Selection of Shanghai JIDU Automobile Co., Ltd.
DUBAI, UAE, Dec. 19, 2025 /PRNewswire/ -- On December 19, 2025, Robo.ai Inc. (NASDAQ: AIIO) officially submitted its application to the provisional administrator of Shanghai JIDU Automobile Co., Ltd. (JIDU Auto), seeking to participate in its...
NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward
Cadmus C. Rich, MD, MBA, as Chief Medical Officer, and Carlos Quezada-Ruiz, MD, FASRS, as Chair of the Scientific Advisory Board, bring invaluable clinical development expertise to VIS-101 Program The ability to attract seasoned ophthalmology...